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A B S T R A C T
The aim of this study is to determine the prevalence of unrecognized dyslipidaemia and a specific correlation between
lipid values and age, gender or ethnic origin in the study population. This retrospective cross-sectional study included 311
subjects who had their lipid profiles checked for the first time in a private hospital in Dubai in a six month – period. The
analysis shows an increased prevalence of Low Density Lipoprotein (LDL) hypercholesterolemia with relatively higher
Low Density Lipoprotein Cholesterol (LDL-c) values in male subjects (p<0.016) as well as with the Middle East ethnic
origin group (p<0.025), while desirable High Density Lipoprotein (HDL-c) was found among female subjects (p=0). The
discordance between the percentages of elevated LDL-c and Total cholesterol (T-c) signifies the role of the LDL-c/non-
HDL-c as the main surrogate for dyslipidaemia as a risk for atherosclerosis, and as a primary target of therapy.
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Introduction
Dyslipidaemia is recognized as a major modifiable
risk factor for cardiovascular diseases1, the leading and
growing cause of mortality in the United Arab Emirates
(UAE)2,3. Elevated levels of Low Density Lipoprotein
cholesterol (LDL-c), Total cholesterol (T-c) and low levels
of High Density Lipoprotein cholesterol (HDL-c) are all
risk factors for developing cardiovascular disease4. Lowe-
ring of LDL-c is regarded as the primary target for the
prevention of cardiovascular diseases in the dyslipidae-
mic patients4.
According to our knowledge there has been no study
to measure the prevalence of dyslipidaemias in the UAE.
We propose that dyslipidaemia along with other major
risk factors is related to the increasing number of cardio-
vascular diseases and mortality rate in the UAE.
Materials and Methods
The population in the retrospective cross-sectional
analysis consists of 516 subjects, aged between 18 and 75,
who had their lipid profiles checked in a private hospital
in Dubai during a six month – period from 01.12.2006 to
31.05.2007.
T-c, LDL-c and HDL-c values were directly measured
(fully automated chemistry analyzer ACE Alera, Alfa
Wassermann). The measurement was in mass units (mg/
dL) and was converted to SI units (mmol/L) by authors
using conversion factor 0.0265.
Laboratory investigations were carried out in the pri-
vate hospital and ordered by general practitioners and
specialist physicians for various health checks (screening
either initiated by physicians due to presenting symp-
toms or requested by patients). Laboratory data were ex-
tracted from hospital’s computer system PulseMedPlus
(Version 4.0, Build version 1.0.0.) and filtered by authors.
All patient files were reviewed by authors and all sub-
jects presenting with an acute cardiac event, morbid obe-
sity, subjects with secondary causes of dyslipidaemia, iso-
lated hypertriglyceredemia, or established hypercholes-
terolemia were excluded. Secondary dyslipidaemia taken
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into account included uncontrolled diabetes mellitus with
HbA1c level above 8.0 %, hypothyroidism, pregnancy,
secondary dyslipidaemia due to estrogen, progestin or
isotretinoin therapy, nephritic syndrome, and chronic re-
nal failure.
After their files had been reviewed and the subjects
with established or secondary dyslipidaemia had been de-
ducted, 311 subjects were checked for the first time dur-
ing the study period. The diagnosis of dyslipidaemia was
made according to the criteria of Adult Treatment Panel
III (ATP III) of the National Cholesterol Education Pro-
gram4. Normal LDL-c was up to 2.6 mmol/l (100 mg/dl),
borderline 2.63 mmol/L – 3.38 mmol/L (101 mg/mL – 130
mg/dL) and high from 3.04 mmol/L (131 mg/dL). Subjects
with cardiovascular disease or cardiovascular disease
equivalent, including coronary artery disease, cerebro-
vascular disease, peripheral vascular disease and diabe-
tes mellitus had a different LDL-c target of 1.82 mmol/L
(70 mg/dL), borderline 1.85 mmol/L – 2.6 mmol/L (71
mg/dL – 100 mg/dL) and high 2.63 mmol/L (101 mg/dL)
and up. Desirable HDL-c was >1.56 mmol/L (60 mg/dL)
and low HDL-c was <1.04 mmol/L (40 mg/mL) for all
subjects. Total cholesterol (T-c) levels were divided into
three categories: normal up to 5.17 mmol/L (199 mg/dL)
borderline from 5.2 mmol/L (200 mg/dL) and high 6.24
mmol/L (240 mg/dL) and up6 for all subjects.
The subjects were subdivided according to gender, age
and ethnic origin. There are five age groups (up to 30y, 31
to 40y, 41 to 50y, 51 to 60y, and 61 and up) and four Eth-
nic origin groups: Europe/North America/ Australia/New
Zealand (E/NA/A/NZ), Middle East (ME), India/Pakistan
(I/P) and other ethnic origins (Ot.). Within Middle East
group we divided the subjects into two categories: the
United Arab Emirates citizenship and non-UAE citizen-
ship. Descriptive statistics and chi-square test and chi-
-square test in pairs have been carried out between dif-
ferent groups to test for significance using software
SPSS 13.0 for Windows.
Results
Group descriptions
Out of 311 subjects included in this study, 195 (63%)
are males and 116 (37%) are females. 63% of all the sub-
jects are of the ME ethnic origin (12% of UAE nationals
and 51% of non UAE nationals), 22% from the E/NA/
A/NZ ethnic origin group, 9% of the I/P origin and 6% of
the Other ethnic origin groups. Distribution per gender
and ethnic origin is shown in Figure 1.
Within ethnic origin groups, there is significant dif-
ference according to gender in group Ot. that has more
female subjects (p<0.006) (73.7%) than other ethnic
groups which have more males than females (70.6% in
E/NA/A/NZ, 64.3% in I/P and 63.3% in ME).
According to the age distribution, patients are divided
into five groups (up to 30y, 31 to 40y, 41 to 50y, 51 to 60y,
and 61 and up). Out of 311 patients 15% are under 30
years of age, 33.6% are from 31 to 40 years, 31.3% are
from 41 to 50 years, 15.3% are from 51 to 60 years and
4.9% are older than 61. Gender distribution shows that
the percentage of males in the group from 41 to 50 yrs
(57.3%) is lower than in overall subject group (62.7%)
while it is significantly higher in the group of 51 to 60
years old subjects (76.6%). In other age groups gender
distribution is close to overall distribution values. Ethnic
origin distribution in age groups also differs from the
overall age group distribution. This distribution is shown
in Figure 2.
The influence of specific group differences
on cholesterol levels
The average value of LDL-c for the whole group is
3.83 mmol/L (SD=1.1). However, the analysis shows dis-
crepancies from the average value depending on gender,
ethnic origin and age.
The ratio of men to women in the overall subject
group is 1.68:1. It has been tested whether a similar ratio
will be kept in different groups of measured LDL-c. In
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Fig. 1. Distribution of gender per ethnic origin (E/NA/A/NZ –
Europe/North America/ Australia/New Zealand, ME-Middle
East, I/P-India/Pakistan, Ot.-Other ethnic origins).




Fig. 2. Distribution of ethnic origin groups per age (EU/NA/AUS/
ZN-Europe/North America/ Australia/New Zealand, ME-Middle
East, IND/PAK-India/Pakistan).
the group of subjects with the normal LDL-c, which
makes 30 out of 311 subjects (9.6%) the representation of
males and females is equal. The same trend is in the
group of subjects with the borderline LDL-c, where the
ratio is 1.15:1, also lower than the overall gender ratio.
This means that only 31.3% of male subjects have a nor-
mal or borderline LDL-c, while with females this per-
centage is 47.4%. In the group with high LDL-c the ratio
between males and females is 2.19:1, much higher than
the overall gender ratio. This shows that out of 195 male
subjects 134 (68.7%) have high LDL-c, while this per-
centage is lower with female subjects (52.6%). As a re-
sult, the analysis shows that gender has significant im-
pact on the LDL-c level (p<0.016).
A similar analysis can be done according to the distri-
bution by the ethnic origin. It has been tested whether
overall distribution by the ethnic origin will be kept in
different groups of the measured LDL-c. In the group of
subjects with normal and borderline LDL-c which makes
116 out of 311 subjects, 30 subjects come from E/NA/
A/NZ. This means that subjects within this ethnic origin
make 25.9% of non-hypercholesterolaemic patients, while
in the overall distribution they represent only 21.9%. In
the ethnic origin groups I/P and Ot. 11 subjects per group
have low or borderline LDL-c, which is 9.5%, whereas the
subjects descending from these ethnic origin groups are
represented in the overall subject distribution with 9%
and 6.1% respectively. Finally, in the ME ethnic origin
group 64 subjects have normal or borderline LDL-c,
which is 55.2%, while the subjects from these ethnic ori-
gin groups are represented in the overall subject groups
with a distribution of 63%. This distribution shows that
the subjects from ME are under-represented in the group
of subjects that have normal or borderline LDL-c. As
shown before, male subjects have higher levels of LDL-c,
and the subjects from ME have more male population
than the overall gender distribution. However, this over-
-representation of male subjects in the ME ethnic origin
is just 2.4% and it cannot justify the under-representa-
tion of the subjects of the ME ethnic origin in the group
with normal or borderline LDL-c. Moreover, the subjects
from ME are 63% of overall subjects, but 67.7% of the
subjects with high LDL-c, while all other ethnic origin
groups have lower representation in high LDL-c than in
overall ethnic origin distribution (p<0.025).
Analysis has also been done according to the age dis-
tribution. It has been tested whether overall age distri-
bution will be kept in different groups with the measured
LDL-c. These data are shown in Table 1. It is evident
that the ratio between the age group participation in
overall subjects and the age group participation in the
level of LDL-c changes the trend on the 40 years of age
borderline as well as the level of LDL-c increases with
age.
Discrepancy between total cholesterol
and LDL-c levels
It has been tested whether there is a linear correla-
tion between T-c level and LDL-c, as T-c may be impacted
on with its other component, HDL-c, the elevation of
which is desirable to lower a cardiovascular risk. 97.4%
of male subjects have low or normal and only 2.6% have
high level of HDL-c while 78.2% of female subjects have
low or normal and 21.7% have high HDL-c. Out of 308
subjects only 30 have high level of HDL-c and 83.3% of
them are females.
Taking into consideration that LDL-c and HDL-c
have different impact on cardiovascular risk and a pro-
portional impact on T-c level, a comparison between
LDL-c and T-c has been done (Table 2). Average values of
T-c, LDL-c and HDL-c per gender and ethnic origin dis-
tributions are shown in Tables 3 and 4.
Discussion
Human atherogenesis starts early in life, and once
initiated, different risk factors influence its progression
and may act synergistically. The long lag between onset
and clinical manifestations of atherosclerosis provides an
opportunity to implement early detection, prevention
and intervention strategies7. More than a century ago, a
Russian pathologist, Antischkow, induced atherosclero-
sis in rabbits by feeding them cholesterol. Since then the
evidence proving that hypercholesterolaemia is strongly
linked to atherosclerosis8 increased. The final link prov-
ing the correlation between hypercholesterolaemia and
atherosclerosis came from the prospective Framingham
study1 and furthermore established by the marked re-
duction of the atherosclerosis related clinical events by
cholesterol lowering intervention9–11. Cardiovascular dis-
eases (coronary and cerebral) represent the leading cause
of mortality in the UAE with 30.37% deaths in 2006, with
a steady growth in the last 10 years2,3, although it has
been regressing steadily in the industrialized world12–15.
In this cross sectional analysis, we evaluated 311 sub-
jects for the prevalence of unrecognized dyslipidaemia,
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TABLE 1
LEVEL OF LDL-C PER AGE GROUPS
<30 31–40 41–50 51–60 >61
Level of LDL-c
Normal 6 12 7 3 1
Borderline 15 33 20 12 7
High 26 59 69 34 7
LDL-c – Low Density Lipoprotein Cholesterol
its relation to different epidemiologic factors (age, gender
and ethnic origin) and whether concordance exists be-
tween hypercholesterolaemia and LDL-hypercholestero-
laemia. The results of this study demonstrated that the
average level of total and LDL cholesterol are signifi-
cantly higher than the levels required for the prevention
of cardiovascular diseases. Hypercholesterolemia is a
worldwide phenomenon, with higher prevalence in the
industrialized world12,13,16,17. This can be attributed to
physical inactivity and unhealthy diet, along with the
growing pandemic of obesity and diabetes mellitus. The
discordance between the percentages of elevated LDL-c
and T-c signifies the role of LDL-C/non-HDL-c as the
main surrogate for dyslipidemia as a risk for atheroscle-
rosis, and as a primary target of therapy4. Results of this
study show that the overall average level of T-c is 5.64
mmol/L (SD=1.17), LDL-c of 3.83 mmol/L (SD 1.1) only.
This shows prevalence of LDL hypercholesterolaemia of
62.7% and T-c hypercholesterolaemia of 25.8%.
The increasing prevalence of cardiovascular mortality
in the UAE, although decreasing in industrialized coun-
tries worldwide, cannot be explained solely by the higher
prevalence of diabetes mellitus, the prevalence charts of
which show worldwide increase18,19. Hypercholesterolae-
mia, on the other hand, may explain this. More investiga-
tions are needed to estimate the prevalence of hyper-
cholesterolaemia, the trends in the last decade and the
correlations with the cardiovascular mortality trends. Prev-
alence of hypercholesterolaemia tends to be higher in
male population and increases with the age, correlates
with the findings from other major prevalence studies
worldwide. The high prevalence can be explained partly
by the selection bias having more of the male gender and
older population, though, the average age and gender
matching T-c and LDL-c values are still among the high-
est investigated. In the Emirate of Dubai there is higher
prevalence of males (76.13%) than females (23.8%)20 while
in our study population there are 63% of males and 37 %
of females. If our study population had the same gender
distribution as the Emirate of Dubai, we would expect
higher average levels of T-c, LDL-c and lower average
levels of HDL-c. The age distribution of our study group
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TABLE 4
AVERAGE VALUES OF T-C, LDL-C AND HDL-c PER ETHNIC ORIGIN
Total E/NA/A/NZ I/P ME Ot.
T-c
Mean 5.64 5.68 5.39 5.67 5.59
SD 1.17 1.19 0.91 1.22 0.89
LDL-c
Mean 3.83 3.72 3.64 3.93 3.48
SD 1.1 1.13 1.13 1.09 0.82
HDL-c
Mean 1.14 1.19 1.1 1.11 1.33
SD 0.29 0.29 0.3 0.27 0.35
T-c – Total Cholesterol, LDL-c – Low Density Lipoprotein Cholesterol, HDL-c – High Density Lipoprotein Cholesterol, SD – Standard
Deviation, E/NA/A/NZ – Europe/North America/ Australia/New Zealand, ME – Middle East, I/P – India/Pakistan, Ot. – Other ethnic
origins, Mean in mmol/L
TABLE 3
AVERAGE VALUES OF T-C, LDL-C AND HDL-C PER GENDER
T-c LDL-c HDL-c
All Male Female All Male Female All Male Female
Mean 5.64 5.76 5.45 3.83 4 3.54 1.14 1.06 1.29
SD 1.17 1.28 0.92 1.1 1.12 1 0.29 0.22 0.33
T-c – Total Cholesterol, LDL-c – Low Density Lipoprotein Cholesterol, HDL-c – High Density Lipoprotein Cholesterol, SD – Standard
Deviation, Mean in mmol/L,
TABLE 2
COMPARISSON BETWEEN LEVEL OF T-C AND LDL-C
Level of LDL cholesterol
Normal Borderline High
Level of total cholesterol
Low 29 61 28
Borderline 1 24 87
High 0 1 79
T-C – Total Cholesterol, LDL-C – Low Density Lipoprotein Cholesterol
differs from the age distribution of the Emirate of
Dubai (30% up to 30 years, 35% 31 to 40 years, 15%
41–50 years, 5% 51 to 60 years and 1% older than 61
years), which means that our study population is older
than the real population of the Emirate of Dubai. Ac-
cording to the survey of the City of Dubai from 1997/
1998, the UAE-nationals were represented with 17%,
Asians with 71%, Westerns and Arabs with 12% of the
total population21. If we assume that the distribution
according to the ethnic origin did not change in the
past decade, then we can see that our study group does
not represent the real ethnic distribution of the Emir-
ate of Dubai. We think the reason behind the discrep-
ancy in the ethnic origin distribution between our
study group and the real population of Dubai and
Northern Emirates is in the access to the private
healthcare, hence higher percentage of the ME and
E/NA/A/NZ ethnic origin groups.
Although T-c has been strongly correlated with the
cardiovascular morbidity and mortality1, the LDL-c is
the primary cause of cardiovascular risk and primary
target of the therapy4. The analysis of the correlation
between T-c and LDL-c shows that out of 230 subjects
who had low or borderline T-c 194 subjects (62.9%) had
high LDL-c, which is a statistically significant discor-
dance that can be explained by the fact that T-c is de-
pendent on different lipids (HDL and non-HDL choles-
terol) having different impacts on cardiovascular
health. The fact that the average LDL-c is lower in
»Other ethnic group« can be attributed to a female
predominance in this group other than the true ethnic
disparity.
Low levels of HDL-c are an independent powerful
prediction of the increased CVD risk. The increasing of
the HDL-c is associated with a decrease of the future
risk of coronary heart disease regardless of the LDL-c
level4,22. In our study 97.4% male subjects and 78.25% fe-
male subjects did not have the HDL-c high enough to de-
crease the cardiovascular risk.
The causes of the bias in our study may be the fact that
the hospital population may not be truly representative of
the overall population trends, the age and gender distribu-
tion affecting the results (more males in most groups)
which might have lead to higher average values from those
representative of the community and that fasting was not
the prerequisite for the lipid profile measurements. How-
ever, LDL-c and HDL-c are not depended on the fasting as
prerequisite, but T-c values can be influenced by trigly-
ceride levels.
Conclusion
Dyslipidaemia (high LDL-c, low HDL-c) prevalence in
Dubai and Northern Emirates appears to be very high.
However, we need a larger scale population based screening
program for the adequate estimation of the burden of the
problem, hence implementing measures to control it. The
increasing cardiovascular mortality may be secondary to
the increasing dyslipidaemia. Total cholesterol is not a good
surrogate marker of the cardiovascular risk. The HDL-c
and the non-HDL-c (LDL-c and triglycerides) are better
surrogate markers.
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PREVALENCIJA NEPREPOZNATE DISLIPIDEMIJE U DUBAIJU I SJEVERNIM EMIRATIMA:
PRESJE^NA STUDIJA BAZIRANA NA PODACIMA IZ BOLNICE
S A @ E T A K
Cilj ovog istra`ivanja je da se odredi u~estalost neotkrivenih dislipidemija i posebna korelacija izmedju vrijednosti
lipida i starosne dobi, spola ili parametara etni~kog porijekla u populaciji obuhva}enoj istra`ivanjem. Ova retrospektiv-
na presje~na studija obuhvatila je 311 osoba koje su prvi puta kontrolirale vrijednosti lipida u jednoj privatnoj bolnici u
Dubaiju u razdoblju od {est mjeseci. Iz analize se vidi da kod mu{kih pacijenata prevladava Low Density Lipoprotein
hiperkolesteremija sa relativno povi{enim Low Density Lipoprotein kolesterolom (LDL-c) (p<0,016) kao i kod etni~ke
grupe koja potje~e s Bliskog istoka (p<0,025), dok su s druge strane po`eljne vrijednosti na|ene kod `ena (p=0). Ne-
srazmjer kod postotaka povi{enog LDL-c i ukupnog kolesterola ukazuje na va`nost uloge LDL-c/ne HDL-c kao glavnog
surogata za dislipidemiju koja predstavlja rizik od ateroskleroze, te kao primarni cilj terapije.
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